Table:
begin	end	state
1	37	cytoplasmic
38	59	transmembrane
60	67	non-cytoplasmic
68	92	transmembrane
93	99	cytoplasmic
100	121	transmembrane
122	124	non-cytoplasmic
125	148	transmembrane
149	168	cytoplasmic
169	189	transmembrane
190	200	non-cytoplasmic
201	220	transmembrane
221	249	cytoplasmic
250	268	transmembrane
269	286	non-cytoplasmic
287	309	transmembrane
310	316	cytoplasmic
317	336	transmembrane
337	342	non-cytoplasmic
343	365	transmembrane
366	375	cytoplasmic
376	397	transmembrane
398	410	non-cytoplasmic
411	429	transmembrane
430	461	cytoplasmic

Input:
>Pf1N1B4_5606 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_5606
VNNMSASITDAKDHAAETAPMKAPNRVKAIMGACSGNLVEWYDFFIYAYTAIYFAASFFP
KGDTTSQLLATAGVFAVGFFMRPLGGWIFGWIADTRGRKVSMIISVFMMCAGSLLIAVMP
TYATIGVAAPILLVVARLIQGLSVGAEYGTGATYISEIATPGRRCFYGSFQYFTIIAGQL
LALMTVVILQQTLTGEELREWGWRIPFFIGALSSIVVVYLRRAMHETATKKDMNRKDAGS
LRGMFKHKRAVALVVAFTIGGSLYFYTFTTYMQKFLVISAGFSPETVSFIMTAALVGFMF
CQPLFGLLADRIGIKAHMLMFSGLAMLLVIPLLYSLQSVSSPFTAFLLVFGGLAIASLYT
PIAGIVKAELFPPAVRALGVGFPYAVGNAAFGGTAEYVALSLRSQGVEAYFFFYVAAVVT
ITFIAAMLMPNLSRYGYISGSGEIEERTGLKGCSKPSAARV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server